BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020

Haitham Hamoda, Susan R. Davis, Antonio Cano, Edward Morris, Sonia Davison, Nicholas Panay, Mary A. Lumsden, Tim Hillard, Tommaso Simoncini

Research output: Contribution to journalLetterOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)49-55
Number of pages7
JournalPost Reproductive Health
Issue number1
Publication statusPublished - Mar 2021
Externally publishedYes

Cite this